½ÃÀ庸°í¼­
»óǰÄÚµå
1424026

ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Àü°³º°, ±¸¼º¿ä¼Òº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

Clinical Communication and Collaboration Market Share, Size, Trends, Industry Analysis Report, By Deployment, By Component, By End-use, By Region, And Segment Forecasts, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 117 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 86¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÀÇ·á Á¾»çÀÚµé »çÀÌ¿¡¼­ À¥ ±â¹Ý ÀÎÅÍÆäÀ̽º¿Í ´Ù¾çÇÑ ¸ð¹ÙÀÏ ±â±â¸¦ ÅëÇØ ½Ç½Ã°£ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ±â´É °£ Áö¿ø Ç÷§Æû¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº VoIP(Voice over IP), È­»óȸÀÇ, º¸¾È ¹®ÀÚ ¸Þ½ÃÁö, ¿ÂÄÝ ½ºÄÉÁÙ¸µ, EHR(Electronic Health Record)¿¡¼­ Áß¿äÇÑ È¯ÀÚ Á¤º¸¿¡ ´ëÇÑ ¾×¼¼½º µîÀÇ ±â¼úÀ» Ȱ¿ëÇÕ´Ï´Ù. º´¿ø Á÷¿ø°ú ÀÇ»ç °£ÀÇ È¿À²ÀûÀÎ Ä¿¹Â´ÏÄÉÀ̼Ç, ƯÈ÷ ¹Ì¼Ç Å©¸®Æ¼ÄÃÇÑ »ç·Ê ó¸®¿Í ¿øÈ°ÇÑ º´¿ø °ü¸® º¸Àå¿¡ ´ëÇÑ ¿ä±¸´Â ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºòµ¥ÀÌÅÍ ºÐ¼® ±â¼úÀÇ ÅëÇÕÀº ÀÌ·¯ÇÑ ¼Ö·ç¼Ç¿¡ Å« ÀÌÁ¡À» °¡Á®´Ù ÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºòµ¥ÀÌÅÍ ºÐ¼®À» Ȱ¿ëÇϸé ÀÇ»ç´Â À¥ ±â¹Ý ¹× ÀüÀÚ Ç÷§Æû¿¡¼­ ¾×¼¼½ºÇÑ µ¥ÀÌÅ͸¦ ±â¹ÝÀ¸·Î ƯÁ¤ Ãß¼¼¸¦ ºÐ¼®ÇÏ°í ¹Ì·¡ÀÇ »ç°ÇÀ» ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â´ÉÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ ¼ÒÅëÀ» ÃËÁøÇÏ¿© Àû½Ã¿¡ °³ÀÔÇϰí Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ºòµ¥ÀÌÅÍ´Â ¶ÇÇÑ È¯ÀÚ Æ÷ÅÐ, À̸ÞÀÏ, Äݼ¾ÅÍ¿Í °°Àº Ä¿¹Â´ÏÄÉÀÌ¼Ç Ç÷§ÆûÀÇ Áö¼ÓÀûÀÎ ¿î¿µÀ» º¸ÀåÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, Äݼ¾ÅÍ Á÷¿øÀº ȯÀÚ µ¥ÀÌÅÍ¿¡ ¾×¼¼½ºÇÏ¿© ÀÇ·á ½Ã½ºÅÛ°úÀÇ °ú°Å »óÈ£ ÀÛ¿ëÀ» ±â¹ÝÀ¸·Î Á¤º¸¿¡ ÀÔ°¢ÇÑ °³ÀÎÈ­ µÈ ´ëÈ­¸¦ ÅëÇØ ȯÀÚÀÇ Àü¹ÝÀûÀÎ °æÇèÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

ºí·ÏüÀÎ ±â¼úÀ» ÀÓ»ó µ¥ÀÌÅÍ °øÀ¯ ¹× °øµ¿ Áø·á¿¡ µµÀÔÇϸé ÀÌ ½ÃÀåÀº Å« ¼ºÀå ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ºí·ÏüÀÎÀº µ¥ÀÌÅÍ Ãâó¸¦ ÃßÀûÇϰí Á¤º¸ ±³È¯ üÀÎÀ» ¾ÏȣȭÇÏ¿© ÀÇ·á Á¤º¸ ±³È¯À» °­È­ÇÏ°í µ¥ÀÌÅÍ Àü¼Û Ȱµ¿À» À§ÇÑ ¾ÈÀüÇÑ »ýŰ踦 ±¸ÃàÇÕ´Ï´Ù. ºí·ÏüÀÎ ±â¼úÀÇ ½Ç¿ëÀûÀÎ ÀÀ¿ë ºÐ¾ß¿¡´Â º¸´Ù È¿À²ÀûÀÎ ÀüÀÚ ÀÇ·á ±â·Ï(EHR) °ü¸®, ÀÎÁõ, ȯÀÚ ÁöºÒÀÚÀÇ ¾ÈÀüÇÑ µî·Ï, º´¿ø ÀÚ¿ø Ȱ¿ë ÃÖÀûÈ­ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ±â¼úÀº Çù»ó Áֱ⸦ ´ÜÃàÇϰí, ³×Æ®¿öÅ© Á¶Á¤À» °­È­Çϸç, ±âÁ¸ Åë½Å ±â¼ú¿¡ µû¸¥ ½Ã°£ Áö¿¬°ú Åë½Å °ÝÂ÷¸¦ ÇØ¼ÒÇϰí, ÀÓ»ó ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ÀÓ»ó Åë½Å ºÐ¾ß¿¡¼­ 5G Àü¼Û ½Ã½ºÅÛÀÇ µµÀÔÀº ´ë·®ÀÇ µ¥ÀÌÅ͸¦ ºü¸£°Ô Àü¼ÛÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î ÀÎÇØ ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ Áغñ°¡ µÇ¾î ÀÖÀ¸¸ç, MRI ¹× X-·¹ÀÌ ½ºÄµ°ú °°Àº µðÁöÅÐ º´¸® µ¥ÀÌÅÍ´Â ¼­·Î ´Ù¸¥ ½Ã¼³ °£¿¡ ½Ç½Ã°£À¸·Î ½±°Ô °øÀ¯µÉ ¼ö ÀÖ°í ±¤´ë¿ª °¡¿ë¼º°ú Ãʰí¼Ó ÀÎÅͳÝÀÌ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¿ø°ÝÁö¿¡ ÀÖ´Â ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿Í Àü¹®°¡µéÀÌ ´ë±â ½Ã°£ ¾øÀÌ È¸ÀǸ¦ ¿­°í, µ¥ÀÌÅ͸¦ ±³È¯Çϰí, °øµ¿ ÀÛ¾÷À» ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ 5G ÀÎÅͳÝÀÇ ÀúÁö¿¬ ±â´ÉÀº ¿ø°Ý ¼ö¼úÀ» Áö¿øÇÏ¿© ¿ø°ÝÁö¿¡ ÀÖ´Â Àǻ簡 ¼ö¼ú ·Îº¿À» »ç¿ëÇÏ¿© ½Ç½Ã°£À¸·Î ¼ö¼úÀ» ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Ŭ¶ó¿ìµå ±â¹Ý ÀÎÇÁ¶ó¸¦ äÅÃÇÏ´Â ÀÓ»ó ½ÇÇè½ÇÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È£½ºÆ®Çü ¹èÆ÷ ºÎ¹®ÀÌ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¼­ºñ½º ºÐ¾ß´Â ¸ðµç ÀÌÇØ°ü°èÀÚ °£ÀÇ º¹ÀâÇÑ ÀÇ·á Ä¿¹Â´ÏÄÉÀÌ¼Ç °£¼ÒÈ­·Î °ßÁ¶ÇÑ ¼ºÀå·üÀ» ±â·Ï

APACÀº ½º¸¶Æ®Æù »ç¿ëÀÚ Áõ°¡¿Í ¿©·¯ ½ºÅ¸Æ®¾÷ÀÇ µîÀåÀ¸·Î ÀÎÇØ ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ÃÖÁ¾ ¿ëµµ ÇöȲ
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ¸ð¹ÙÀÏ µð¹ÙÀ̽º ÅëÇÕ¿¡ ÀÇÇØ ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷(CC&C) ¼Ö·ç¼Ç ¼ö¿ä°¡ ÃËÁø
      • ½Ç½Ã°£ Åë½Å ¼ö¿ä
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • º¸¾È°ú ÇÁ¶óÀ̹ö½Ã ¹®Á¦
  • PESTEL ºÐ¼®
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå ÃÖÁ¾ ¿ëµµ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Àü°³º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • È£½ºÆ®
  • ¿ÂÇÁ·¹¹Ì½º

Á¦6Àå ¼¼°èÀÇ ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÄÄÆ÷³ÍÆ®º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¼Ö·ç¼Ç
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • º´¿ø
  • ÀÓ»ó °Ë»ç½Ç
  • ÀÓ»ó °Ë»ç½Ç
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå Æò°¡, Áö¿ª, 2019-2032³â
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Àü°³º°, 2019-2032³â
    • ºÏ¹Ì : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • ºÏ¹Ì : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¹Ì±¹
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ij³ª´Ù
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - À¯·´
    • À¯·´ : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Àü°³º°, 2019-2032³â
    • À¯·´ : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • À¯·´ : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¿µ±¹
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ÇÁ¶û½º
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - µ¶ÀÏ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ½ºÆäÀÎ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ³×´ú¶õµå
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ·¯½Ã¾Æ
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Àü°³º°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - Áß±¹
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - Àεµ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¸»·¹À̽þÆ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ÀϺ»
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - Àεµ³×½Ã¾Æ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - Çѱ¹
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Àü°³º°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ±¸¼º¿ä¼Òº°, 2019-2032³â
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - UAE
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - À̽º¶ó¿¤
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, Àü°³º°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¸ß½ÃÄÚ
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ºê¶óÁú
    • ÀÓ»ó Ä¿¹Â´ÏÄÉÀÌ¼Ç ¹× Çù¾÷ ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦9Àå °æÀï »óȲ

  • È®Àå°ú Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Avaya LLC
  • Cisco Systems, Inc
  • Cisco Systems, Inc
  • HILLROM & WELCH ALLYN(Baxter International)
  • Intel Corporation
  • Microsoft
  • NEC Corporation
  • Oracle
  • Plantronics, Inc
  • Spok Holdings Inc.
  • TNS Inc.(AGNITY Inc.)
  • Vocera Communications
ksm 24.02.23

The global clinical communication and collaboration market size is expected to reach USD 8.60 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Communication and Collaboration Market Share, Size, Trends, Industry Analysis Report, By Deployment (Hosted, On-premise), By Component (Solution, Services), By End-use (Hospitals, Clinical Labs, Physicians), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing inclination among healthcare practitioners to utilize cross-functional support platforms, enabling them to engage in real-time communication through web-based interfaces or various mobile devices, is fueling market growth. These platforms leverage technologies such as Voice over IP (VoIP), video conferencing, secure text messaging, on-call scheduling, and access to critical patient information from Electronic Health Records (EHR) whenever necessary. The demand for efficient communication between hospital staff and doctors, especially in handling mission-critical cases and ensuring seamless hospital management, is anticipated to drive the adoption of clinical communication and collaboration solutions.

The integration of big data analytics technology is anticipated to bring substantial benefits to these solutions. By utilizing big data analytics, doctors can analyze specific trends and anticipate future events based on data accessed from web-based or electronic platforms. This capability enables timely intervention and improved continuity of care by facilitating communication among patients and healthcare providers. Big data also ensures the continuous operation of communication platforms like patient portals, emails, and call centers. For instance, call center representatives can access patient data to engage in informed and personalized conversations based on prior interactions with the healthcare system, enhancing the overall patient experience.

The incorporation of blockchain technology into clinical data sharing and collaborative care presents substantial growth opportunities for the market. Blockchain enhances health information exchange by tracing data origin and encrypting the information exchange chain, creating a secure ecosystem for data transfer activities. Practical applications of blockchain technology include more efficient Electronic Health Record (EHR) management, authentication, secure registration of patient payment sources, and optimized hospital resource utilization. The technology is expected to reduce negotiation cycles, enhance network coordination, address time delays and communication gaps associated with legacy communication technology, and streamline clinical processes.

The introduction of the 5G delivery system in clinical communication is poised to offer substantial growth opportunities for the market, given its capability to transmit large volumes of data quickly. Digital pathological data, including MRI and X-ray scans, can be effortlessly shared in real-time across different facilities, fostering high-bandwidth availability and ultra-high-speed internet. This advancement facilitates remote healthcare providers and specialists to convene, exchange data, and collaborate without encountering latency. Moreover, the low-latency feature of 5G Internet is expected to support telesurgery, enabling doctors in remote locations to perform real-time surgeries using surgical robots.

Clinical Communication and Collaboration Market Report Highlights

The hosted deployment segment will grow rapidly, owing to the rise in clinical labs adopting cloud-based infrastructure

The services segment experienced a robust growth rate on account of streamlining its complex medical communication across all its stakeholders

APAC will grow at a substantial pace, owing to the rise in smartphone users and the advent of several start-ups

The global players include Avaya, Cisco Systems, Halo Health, Intel Corporation, Microsoft, NEC Corporation & Oracle.

Polaris Market Research has segmented the clinical communication and collaboration market report based on deployment, component, end use, and region:

Clinical Communication and Collaboration, Deployment Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hosted
  • On-premise

Clinical Communication and Collaboration, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • Solution
  • Services

Clinical Communication and Collaboration, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Small Hospitals
  • Medium Hospitals
  • Large Hospitals
  • Clinical Labs
  • Physicians
  • Others

Clinical Communication and Collaboration, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Clinical Communication and Collaboration Market Insights

  • 4.1. Clinical Communication and Collaboration Market - End Use Snapshot
  • 4.2. Clinical Communication and Collaboration Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of mobile devices propels the demand for clinical communication and collaboration (CC&C) solutions
      • 4.2.1.2. Demand for Real-Time Communication
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Security and Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Clinical Communication and Collaboration Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Clinical Communication and Collaboration Market, by Deployment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
  • 5.3. Hosted
    • 5.3.1. Global Clinical Communication and Collaboration Market, by Hosted, by Region, 2019-2032 (USD Billion)
  • 5.4. On-premise
    • 5.4.1. Global Clinical Communication and Collaboration Market, by On-premise, by Region, 2019-2032 (USD Billion)

6. Global Clinical Communication and Collaboration Market, by Component

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
  • 6.3. Solution
    • 6.3.1. Global Clinical Communication and Collaboration Market, by Solution, by Region, 2019-2032 (USD Billion)
  • 6.4. Services
    • 6.4.1. Global Clinical Communication and Collaboration Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Clinical Communication and Collaboration Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Clinical Communication and Collaboration Market, by Hospitals, By Region, 2019-2032 (USD Billion)
    • 7.3.2. Small Hospitals
      • 7.3.2.1. Global Clinical Communication and Collaboration Market, by Small Hospitals, By Region, 2019-2032 (USD Billion)
    • 7.3.3. Medium Hospitals
      • 7.3.3.1. Global Clinical Communication and Collaboration Market, by Medium Hospitals, By Region, 2019-2032 (USD Billion)
    • 7.3.4. Large Hospitals
      • 7.3.4.1. Global Clinical Communication and Collaboration Market, by Large Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Clinical Labs
    • 7.4.1. Global Clinical Communication and Collaboration Market, by Clinical Labs, By Region, 2019-2032 (USD Billion)
  • 7.5. Clinical Labs
    • 7.5.1. Global Clinical Communication and Collaboration Market, by Clinical Labs, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Clinical Communication and Collaboration Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Clinical Communication and Collaboration Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Clinical Communication and Collaboration Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Clinical Communication and Collaboration Market - North America
    • 8.3.1. North America: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
    • 8.3.2. North America: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.3.4. Clinical Communication and Collaboration Market - U.S.
      • 8.3.4.1. U.S.: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.3.5. Clinical Communication and Collaboration Market - Canada
      • 8.3.5.1. Canada: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
  • 8.4. Clinical Communication and Collaboration Market - Europe
    • 8.4.1. Europe: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.4. Clinical Communication and Collaboration Market - UK
      • 8.4.4.1. UK: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.5. Clinical Communication and Collaboration Market - France
      • 8.4.5.1. France: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.6. Clinical Communication and Collaboration Market - Germany
      • 8.4.6.1. Germany: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.7. Clinical Communication and Collaboration Market - Italy
      • 8.4.7.1. Italy: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.8. Clinical Communication and Collaboration Market - Spain
      • 8.4.8.1. Spain: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.9. Clinical Communication and Collaboration Market - Netherlands
      • 8.4.9.1. Netherlands: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.4.10. Clinical Communication and Collaboration Market - Russia
      • 8.4.10.1. Russia: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
  • 8.5. Clinical Communication and Collaboration Market - Asia Pacific
    • 8.5.1. Asia Pacific: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.5.4. Clinical Communication and Collaboration Market - China
      • 8.5.4.1. China: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.5.5. Clinical Communication and Collaboration Market - India
      • 8.5.5.1. India: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.5.6. Clinical Communication and Collaboration Market - Malaysia
      • 8.5.6.1. Malaysia: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.5.7. Clinical Communication and Collaboration Market - Japan
      • 8.5.7.1. Japan: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.5.8. Clinical Communication and Collaboration Market - Indonesia
      • 8.5.8.1. Indonesia: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.5.9. Clinical Communication and Collaboration Market - South Korea
      • 8.5.9.1. South Korea: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
  • 8.6. Clinical Communication and Collaboration Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.6.4. Clinical Communication and Collaboration Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.6.5. Clinical Communication and Collaboration Market - UAE
      • 8.6.5.1. UAE: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.6.6. Clinical Communication and Collaboration Market - Israel
      • 8.6.6.1. Israel: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.6.7. Clinical Communication and Collaboration Market - South Africa
      • 8.6.7.1. South Africa: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
  • 8.7. Clinical Communication and Collaboration Market - Latin America
    • 8.7.1. Latin America: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.7.4. Clinical Communication and Collaboration Market - Mexico
      • 8.7.4.1. Mexico: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.7.5. Clinical Communication and Collaboration Market - Brazil
      • 8.7.5.1. Brazil: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)
    • 8.7.6. Clinical Communication and Collaboration Market - Argentina
      • 8.7.6.1. Argentina: Clinical Communication and Collaboration Market, by Deployment , 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Clinical Communication and Collaboration Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Clinical Communication and Collaboration Market, by Component, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Avaya LLC
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Cisco Systems, Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cisco Systems, Inc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. HILLROM & WELCH ALLYN (Baxter International)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Intel Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Microsoft
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. NEC Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Oracle
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Plantronics, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Spok Holdings Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. TNS Inc. (AGNITY Inc.)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Vocera Communications
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
      • 10.12.3.1. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦